EGFR敏感突变的晚期肺腺癌一线化疗与吉非替尼联合治疗的随机对照研究
金 波,张岩巍,韩宝惠,等
Randomized controlled trial of chemotherapy plus gefitinib as first-line treatment for patients with advanced EGFR mutation-positive lung adenocarcinoma
JIN Bo, ZHANG Yanwei, HAN Baohui, et al
中国癌症杂志
.
2015, (10): 761
-767
.
DOI: 10.3969/j.issn.1007-3969.2015.10.001
